Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Ferring Pharmaceuticals, Inc. and Merck & Co., Inc.

Bladder Cancer Working Group: Practical Application of Immunotherapeutic Strategies to Optimize Patient Outcomes, Next Steps to Move the Field Forward

Bladder Cancer Working Group: Practical Application of Immunotherapeutic Strategies to Optimize Patient Outcomes, Next Steps to Move the Field Forward


May 4, 2019

McCormick Place West
W375A (Level 3)
2301 S. Martin Luther King Drive
Chicago, Illinois 60616

Dinner and Registration: 5:30 PM – 6:00 PM
Program: 6:00 PM – 8:00 PM
W375A (Level 3)

Overview

Bladder Cancer Working Group: Practical Application of Immunotherapeutic Strategies to Optimize Patient Outcomes, Next Steps to Move the Field Forward is a live symposium to be held adjunct to the annual urology meeting in Chicago. Now, even while clinicians are sorting through data from clinical studies of single-agent immunotherapy for advanced/metastatic urothelial cancer (UC), the field is poised to pivot again as a multitude of ongoing clinical studies are evaluating single-agent and combination immunotherapy strategies across all stages of bladder cancer. Additionally, novel agents are being studied to address the unmet needs of patients who with UC that is refractory to immune checkpoint inhibitor therapy. Use of these agents across multiple lines of therapy for advanced UC and the potential expansion of their use to early-stage disease makes it imperative that urologists, as the primary care provider for patients with early-stage disease and the gatekeep for referral to other specialists, understand both new data and best practices related to the use of immunotherapy, including proactively monitoring, mitigating, and managing immune-related adverse events. This interactive symposium will bring together a multidisciplinary faculty of renowned experts in urology, medical oncology, and immunotherapy to review practice-changing data and discuss their impact on patient care. Brief didactic presentations will be followed by “real-world” clinical case presentations and discussions that facilitate interpretation and application of the evidence. The faculty will also share their forward-looking perspectives on the bladder cancer treatment horizon based on recently reported and anticipated clinical trial data. Come hear the experts’ talk about your most pressing clinical questions and challenges, including topics such as optimal treatment selection, duration of treatment, sequencing, as well as identification and management of pseudoprogression and unique toxicities.

Target Audience

This educational program is directed toward urologists, oncologists, and researchers interested in the treatment of bladder cancers. Nurse practitioners, physician assistants, nurses, and other healthcare professionals involved in the treatment and management of patients with bladder cancers will be invited to participate.

Educational Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Identify the rationale for using immunotherapy-based approaches to treat bladder cancer
  • Analyze key data from clinical trials of immunotherapies and other emerging agents for bladder cancer
  • Consider practice-changing evidence from clinical trials of immunotherapies, cytotoxic agents, and targeted therapies during multidisciplinary, team-based care planning for patients with bladder cancer
  • Outline immune-related adverse events and best practices for their mitigation and management

Acknowledgment of Commercial Support

This activity is supported by educational grants from Ferring Pharmaceuticals, Inc. and Merck & Co., Inc.

Program Chair

Daniel P. Petrylak, MD
Professor of Medicine (Medical Oncology) and Urology
Director, Prostate and GU Medical Oncology
Director, Prostate Cancer Translational Research Group
Yale Cancer Center
New Haven, CT


Registration

2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
 
Registration Fee - Free

Please note that attendance is on a first-come, first-served basis. Please arrive early to ensure your spot!

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.    

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.



Register

You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information


Registration Information


Professional Information


Specialties*

Submit
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
 123456
78910111213
14151617181920
21222324252627
28293031
Filter By